Zobrazeno 1 - 10
of 231
pro vyhledávání: '"Dennis C. Sgroi"'
Autor:
Dennis C. Sgroi, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle Salunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Karen J. Taylor, Elena Brachtel, Sarah Pirrie, Catherine A. Schnabel, Daniel Rea, John M. S. Bartlett
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-10 (2022)
Abstract Background Multiple clinical trials demonstrate consistent but modest benefit of adjuvant extended endocrine therapy (EET) in HR + breast cancer patients. Predictive biomarkers to identify patients that benefit from EET are critical to balan
Externí odkaz:
https://doaj.org/article/f73219a1ffd7495699a8f9ef0b2330f6
Autor:
Brock Schroeder, Yi Zhang, Olle Stål, Tommy Fornander, Adam Brufsky, Dennis C. Sgroi, Catherine A. Schnabel
Publikováno v:
npj Breast Cancer, Vol 3, Iss 1, Pp 1-3 (2017)
Abstract Patients with early-stage, hormone receptor–positive breast cancer with favorable clinicopathologic features are often not recommended for extended endocrine therapy. However, even patients with T1N0 disease remain at significant risk of d
Externí odkaz:
https://doaj.org/article/92e90599335f479b9f2cb277f9642bd4
Autor:
Leif W. Ellisen, A. John Iafrate, Dennis C. Sgroi, Paul E. Goss, Aditya Bardia, Long Phi Le, Dianne M. Finkelstein, Nora Horick, Jessica St. Louis, Gustavo Werutsky, Sahsine Tolunay, Ismet Tasdelen, Pedro Liedke, Henry Gomez, Sahsuvar Gökgöz, Ünal Egeli, Elif Demirdögen, Marcio Debiasi, Yanin Chavarri-Guerra, Arlene Chan, Nuran Beşe, Carlos Barrios, Tanja Badovinac-Crnjevic, Mehrad Tavallai, Allison Macleay, Srinivas Vinod Saladi, Piiha-Lotta Jerevall, Kristofer Patel, Jesse Lee, Andrew Schultz, Zongli Zheng, Sheng Sun, Maristela L. Onozato, Karina J. Matissek
Supplementary Figure S1-S6 and Supplementary Tables S1-S8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::522c72c1019cf2f67606a2b851bf8c63
https://doi.org/10.1158/2159-8290.22531756.v1
https://doi.org/10.1158/2159-8290.22531756.v1
Autor:
Daphne W. Bell, Daniel A. Haber, Dennis C. Sgroi, Lee Zou, Brian E. Henderson, Matthew L. Freedman, Judy E. Garber, Kristen M. Shannon, Lindsey E. Ulkus, Sara M. Haserlat, Patricia L. Harris, Taryn A. Schiripo, Doke C.R. Wahrer, Brian W. Brannigan, Young-Han Song, Jianmin Zhang
Supplementary Data from Prevalence and Functional Analysis of Sequence Variants in the ATR Checkpoint Mediator Claspin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48b005814580ad315c1e51ec68ceabf3
https://doi.org/10.1158/1541-7786.22519500.v1
https://doi.org/10.1158/1541-7786.22519500.v1
Autor:
Sridhar Ramaswamy, Laura J. Van't Veer, Daniel A. Haber, Rene Bernards, Karleen Habin, Sonika Dahiya, Anitha Male, Annuska M. Glas, Tako J. Bruinsma, Paula D. Ryan, Dennis C. Sgroi, Ben S. Wittner
Purpose: Most node-negative breast cancer patients are older and postmenopausal and are increasingly being offered adjuvant chemotherapy despite their low overall risk of distant relapse. A molecular diagnostic test with high negative predictive valu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::673e7d7d02070180f0db4476d1a70710
https://doi.org/10.1158/1078-0432.c.6516784
https://doi.org/10.1158/1078-0432.c.6516784
Autor:
Daniel W. Rea, Catherine A. Schnabel, Sarah J. Pirrie, Elena F. Brachtel, Karen J. Taylor, Sarah Thornber, Lucy Doos, Ikhlaaq Ahmed, Ranelle C. Salunga, Tammy Piper, Yi Zhang, Kai Treuner, Dennis C. Sgroi, John M.S. Bartlett
Purpose:The Breast Cancer Index (BCI) HOXB13/IL17BR (H/I) ratio predicts benefit from extended endocrine therapy in hormone receptor–positive (HR+) early-stage breast cancer. Here, we report the final analysis of the Trans-aTTom study examining BCI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35f36da423f3794918ed8022d0689f3d
https://doi.org/10.1158/1078-0432.c.6532682.v1
https://doi.org/10.1158/1078-0432.c.6532682.v1
Autor:
Sridhar Ramaswamy, Laura J. Van't Veer, Daniel A. Haber, Rene Bernards, Karleen Habin, Sonika Dahiya, Anitha Male, Annuska M. Glas, Tako J. Bruinsma, Paula D. Ryan, Dennis C. Sgroi, Ben S. Wittner
Supplementary Table S1 from Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1259dfe9b73fdfa650a30e15794cafac
https://doi.org/10.1158/1078-0432.22439290.v1
https://doi.org/10.1158/1078-0432.22439290.v1
Autor:
Daphne W. Bell, Maria J. Merino, Dennis C. Sgroi, Andrew K. Godwin, Sarah Fogoros, Jessica C. Price, Meghan L. Rudd
Purpose: The goal of this study was to comprehensively define the incidence of mutations in all exons of PIK3CA in both endometrioid endometrial cancer (EEC) and nonendometrioid endometrial cancer (NEEC).Experimental Design: We resequenced all coding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb86422de90a876698fd56f987fd6912
https://doi.org/10.1158/1078-0432.c.6518952
https://doi.org/10.1158/1078-0432.c.6518952
Autor:
Dennis C. Sgroi, Catherine A. Schnabel, Hannah Nolan, Amy Ly, Piiha-Lotta Jerevall, Brock E. Schroeder, Yi Zhang
Supplemental Table 1 shows the clinical and pathologic characteristics for patients with early vs late distant recurrences.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1c3b15c4007b9c1848f56166094de7
https://doi.org/10.1158/1078-0432.22466381
https://doi.org/10.1158/1078-0432.22466381
Autor:
Dennis C. Sgroi, Catherine A. Schnabel, Hannah Nolan, Amy Ly, Piiha-Lotta Jerevall, Brock E. Schroeder, Yi Zhang
Supplemental Figure 4 shows the prognostic performance of BCIN+ for overall 15-year (A,C) and late post-5-year (B,D) distant recurrence in HER2-negative patients with 1-3 positive nodes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef209779453dd202a787f280e967695
https://doi.org/10.1158/1078-0432.22466387.v1
https://doi.org/10.1158/1078-0432.22466387.v1